Windtree Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing treatments for heart failure and cancer. The company is currently conducting clinical trials for acute heart failure and associated cardiogenic shock, as well as genotype-specific treatment-resistant hypertension. The company is also researching and developing treatments for skin malignancies and solid tumors. Based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | Pennsylvania |
Employees | 20 |
Founded | |
Financials | |
|---|---|
Market Capitalization | 2.26M |
Revenue | |
Operating Income | -20.81M |
Operating Margin | |
Net Income | -5.96M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 3983 / 5373 |
Sector : Healthcare | 507 / 1144 |
Industry : Biotechnology | 188 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 5529 / 5565 |
Sector : Healthcare | 1162 / 1182 |
Industry : Biotechnology | 661 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 3247 / 5436 |
Sector : Healthcare | 261 / 1164 |
Industry : Biotechnology | 71 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4808 / 5330 |
Sector : Healthcare | 958 / 1174 |
Industry : Biotechnology | 490 / 667 |